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Takotsubo cardiomyopathy is a poorly understood myocar-
dial disorder that is generally considered to be a transient,
non-ischaemic disease with a favourable prognosis in post-
menopausal women. Its profile is typically characterised by
cardiomyopathy involving regional wall motion abnormali-
ties after a stressful event, but is also associated with serious
life-threatening complications in up to 10 % of cases [1].
While this disease entity has received a large amount of
attention over the past years, the aetiology still remains an
enigma. Although it has been postulated that catecholamine
and endothelin excess likely play a central role, the exact
pathophysiology is poorly understood. The triggering event
is typically diverse, ranging from severe emotional stress
and even pleasant emotional stressors, but often no trigger
can be identified [2].
The diagnosis of takotsubo cardiomyopathy is challeng-
ing, and can only be made after significant coronary artery
disease has been ruled out. Only modestly raised tro-
ponins and often a vastly raised B-type natriuretic pep-
tide are often seen. Finally, this disease presents in many
shades of grey, the typical apical ballooning, but also mid-
ventricular, basal, and focal subtypes have been described
(for different clinical examples see http://specklepedia.com/
examples/miscellaneous/tako-tsubo-cardiomyopathy/).
To further elucidate this still relatively unknown disease,
the current issue of the Netherlands Heart Journal features
three unique articles from different research groups, each
addressing a specific and unrelated topic associated with the
same disease. This work will likely further help us grasp
this heterogeneous disease.
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The article by Otten et al. [3] presents a Dutch cohort
of STEMI patients from a single large peripheral hospi-
tal. Their main finding was that the diagnosis of takotsubo
cardiomyopathy in this specific patient cohort seemed to
increase during the years, mirroring the amount of publica-
tions on PubMed. Nevertheless, the total number of tako-
tsubo patients remained very low (0.4 % in the 2002–2007
period to 0.7 % in the 2008–2013 period). The reason for
this increase is most likely a combination of an increased
awareness and early patient presentation to the catheteri-
sation lab. While we expect the number of publications
to keep on increasing, the total incidence of this disease
will most likely remain close to 1 % in this specific patient
population. This increased awareness seems to be an im-
portant factor, considering the growing number of articles
on PubMed, but also represented by the worldwide interest
on the Google search engine for takotsubo cardiomyopathy
(Fig. 1). We would like to comment on the recommenda-
tion to stop ACE inhibitors and continue beta blockade, as
suggested by the authors, this recommendation is not sup-
ported by a recent large observational cohort [1], where beta
blockers did not seem to have any protective effect in the re-
currence of takotsubo cardiomyopathy, while patients with
ACE inhibitors seemed to have significantly better survival.
A large Polish cohort, published by Zalewska-Adamiec
et al. [4], gives us some more insight into the long-term
data on hard clinical outcome in takotsubo patients. Al-
though serious cardiac complications (cardiogenic shock,
pulmonary oedema, cardiac arrest, and cardiac death) oc-
curred less compared with STEMI patients, this was still
seen in almost 15 % of the entire takotsubo cardiomyopa-
thy cohort. Of particular importance is the relatively high
number of patients with a cardiac rupture: 3 % compared
with 1 % in the STEMI group. This high percentage of car-
diac complications is not new since these numbers were also
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Fig. 1 Google search index for
‘Takotsubo cardiomyopathy’
over time
described in a large cohort of takotsubo patients, which was
recently published in the New England Journal of Medicine
[1]. Therefore, we think we can firmly conclude that the
notion that takotsubo cardiomyopathy is a benign disease
seems a misconception. These serious complications oc-
cur during hospitalisation or shortly afterwards, while in
STEMI patients events keep on occurring throughout the
first year, a finding fitting both disease entities. Indeed,
cardiac death among the takotsubo patients was almost neg-
ligible during the two year follow-up period. One limitation
of the data is that spasm and spontaneous thrombolysis in
the takotsubo group could not be excluded. Furthermore,
what is unknown from this publication is what precisely
happened in their control group. The amount of patients
receiving a primary intervention is unknown and the extent
of myocardial damage to the myocardium has not been re-
ported. However, the importance of these unknown factors
is irrelevant when we solely focus on the takotsubo patients
in this paper (since a real comparable control group for this
patient category is intangible).
The final paper by Smeijers and colleagues [5] shifts our
focus to psychological distress, illness-related anxiety and
personality factors approximately two years after the event.
This study uses thorough assessment tools in a small tako-
tsubo patient cohort and compared their findings with heart
failure patients and healthy controls. The lesson learned
in this study is that patients with takotsubo cardiomyopa-
thy had higher levels of depressive symptoms and illness-
related anxiety compared with healthy controls. One of
the striking findings is that both depression and anxiety are
comparable between takotsubo patients and heart failure
patients. Indeed, approximately one-third of takotsubo car-
diomyopathy patients and heart failure patients cope with
symptoms of depression. This raises the question whether
we are overlooking or undertreating these patients?
The authors of this paper conclude that ‘the possibil-
ity that the unpredictable nature of takotsubo cardiomy-
opathy and the lack of a sustained underlying cardiac dis-
ease process may result in increased illness-related anxi-
ety and depressive symptoms in TTC patients’. Although
this is a valid assumption, we do not know whether or not
these symptoms were present in these individuals before
the episode of takotsubo cardiomyopathy. a recent report
has shown us that more than half the takotsubo patients
(55.8 %) had a history or an acute episode of a neurologi-
cal or psychiatric disorder, conditions that were evident in
only 25.7 % of patients with an acute coronary syndrome
[1]. The high prevalence of neurological and psychiatric
disorders was also reflected by the fact that a substantial
number of patients were taking one or more antidepressants
(17.1 %).
Besides the abovementioned conclusions, we may also
conclude that the increased interest in takotsubo cardiomy-
opathy has led to many new and long-lasting insights, but
thus far not to an easy diagnostic (imaging) biomarker nor
treatment. The ESC Heart Failure Association has recently
published, for the first time, a position statement, giving
a comprehensive review, recommendations and future di-
rections using the current state of knowledge on this in-
triguing acute heart failure syndrome [9].
The intriguing part is that the number of new questions
raised by published articles is increasing at the same pace as
our gained knowledge from these data. Is the mechanism in
takotsubo cardiomyopathy, for example, a potential clinical
cardioprotective mechanism? And if indeed so, can we find
this switch to prevent damage also for other diseases?
Fig. 1 illustrates a Google Trends query, demonstrating
an increase in worldwide interest over time on Google, the
most widely used global search engine. The y-axis rep-
resents the ‘takotsubo cardiomyopathy’ syndrome portion
of Google search volume after indexing and normalisation.
Peak 1 probably represents the increased attention by sev-
eral high impact papers in 2005 [6, 7]. Peak 2 in Febru-
ary 2014 probably represents the worldwide news coverage
‘you can die from a broken heart’ based on a JAMA Internal
Medicine article by Carey et al. [8].
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